German healthcare spending soars:
This article was originally published in Clinica
Executive Summary
Germany spent a total of DM 107.5 billion on medical aids, implants, dental replacements, blood products and pharmaceuticals in 1998, an increase of 4.4% over 1996. A further DM 106.7 billion was spent on treatments by medical staff. An estimated DM 5,030 per capita of the population, up DM 70 since 1996. Expenditure within the inpatient sector rose by 3.5% and within the outpatient sector by 2% during this period. Germany has seen an increase of 28.7% in spending within the healthcare sector since 1992. The total expenditure within in the sector in 1998 was DM 412.7 billion, equivalent to 10.9% of GDP.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.